Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig R Rayner

Showing results (51-60 of 68) with videos related to

Pageof 7
Sort By:
Basic & Clinical Pharmacology & Toxicology|May 20, 2011
Absence of adverse effects of oseltamivir on sleep: a double-blind, randomized study in healthy volunteers in JapanNaohisa Uchimura, Hiroo Kuwahara, Yuji Kumagai, et al.
Advances in Therapy|October 12, 2012
Post-marketing assessment of neuropsychiatric adverse events in influenza patients treated with oseltamivir: an updated reviewStephen Toovey, Eric P Prinssen, Craig R Rayner, et al.
CPT: Pharmacometrics & Systems Pharmacology|December 9, 2024
Advancing pharmacometrics in Africa-Transition from capacity development toward job creationGoonaseelan Colin Pillai, Samer Mouksassi, Innocent G Asiimwe, et al.
Antimicrobial Agents and Chemotherapy|February 12, 2014
Clinical population pharmacokinetics and toxicodynamics of linezolidLauren M Boak, Craig R Rayner, M Lindsay Grayson, et al.
Antimicrobial Agents and Chemotherapy|May 15, 2013
Population pharmacokinetics of oseltamivir: pediatrics through geriatricsMohamed A Kamal, Scott A Van Wart, Craig R Rayner, et al.
The Lancet. Global Health|April 18, 2021
How COVID-19 has fundamentally changed clinical research in global healthJay J H Park, Robin Mogg, Gerald E Smith, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 16, 2012
Role of the intestinal peptide transporter PEPT1 in oseltamivir absorption: in vitro and in vivo studiesAgnès Poirier, Sara Belli, Christoph Funk, et al.
The American Journal of Tropical Medicine and Hygiene|August 24, 2020
Accelerating Clinical Evaluation of Repurposed Combination Therapies for COVID-19Craig R Rayner, Louis Dron, Jay J H Park, et al.
Infection and Drug Resistance|December 30, 2020
The Landscape of Emerging Randomized Clinical Trial Evidence for COVID-19 Disease Stages: A Systematic Review of Global Trial RegistriesAlison Dillman, Michael J Zoratti, Jay J H Park, et al.
Clinical Pharmacology and Therapeutics|February 8, 2021
Model-Informed Drug Development for Anti-Infectives: State of the Art and FutureCraig R Rayner, Patrick F Smith, David Andes, et al.
Pageof 7

Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
Basic & Clinical Pharmacology & Toxicology|May 20, 2011
Absence of adverse effects of oseltamivir on sleep: a double-blind, randomized study in healthy volunteers in JapanNaohisa Uchimura, Hiroo Kuwahara, Yuji Kumagai, et al.
Advances in Therapy|October 12, 2012
Post-marketing assessment of neuropsychiatric adverse events in influenza patients treated with oseltamivir: an updated reviewStephen Toovey, Eric P Prinssen, Craig R Rayner, et al.
CPT: Pharmacometrics & Systems Pharmacology|December 9, 2024
Advancing pharmacometrics in Africa-Transition from capacity development toward job creationGoonaseelan Colin Pillai, Samer Mouksassi, Innocent G Asiimwe, et al.
Antimicrobial Agents and Chemotherapy|February 12, 2014
Clinical population pharmacokinetics and toxicodynamics of linezolidLauren M Boak, Craig R Rayner, M Lindsay Grayson, et al.
Antimicrobial Agents and Chemotherapy|May 15, 2013
Population pharmacokinetics of oseltamivir: pediatrics through geriatricsMohamed A Kamal, Scott A Van Wart, Craig R Rayner, et al.
The Lancet. Global Health|April 18, 2021
How COVID-19 has fundamentally changed clinical research in global healthJay J H Park, Robin Mogg, Gerald E Smith, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 16, 2012
Role of the intestinal peptide transporter PEPT1 in oseltamivir absorption: in vitro and in vivo studiesAgnès Poirier, Sara Belli, Christoph Funk, et al.
The American Journal of Tropical Medicine and Hygiene|August 24, 2020
Accelerating Clinical Evaluation of Repurposed Combination Therapies for COVID-19Craig R Rayner, Louis Dron, Jay J H Park, et al.
Infection and Drug Resistance|December 30, 2020
The Landscape of Emerging Randomized Clinical Trial Evidence for COVID-19 Disease Stages: A Systematic Review of Global Trial RegistriesAlison Dillman, Michael J Zoratti, Jay J H Park, et al.
Clinical Pharmacology and Therapeutics|February 8, 2021
Model-Informed Drug Development for Anti-Infectives: State of the Art and FutureCraig R Rayner, Patrick F Smith, David Andes, et al.
Pageof 7